A Phase 3, Single-Arm Study of CG0070 in Subjects with Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG)

被引：0
|
作者：
Uchio, Edward [1 ]
Lamm, Donald [2 ]
Anderson, Paul D. [3 ]
Tran, Ben [4 ]
Kamat, Ashish [5 ]
McAdory, John [6 ]
Keel, Melody [6 ]
Grandi, Paola [6 ]
Burke, James [6 ]
机构：
[1] Univ Calif Irvine, Irvine, CA USA
[2] BCG Oncol, Phoenix, AZ USA
[3] Royal Melbourne Hosp, Melbourne, Vic, Australia
[4] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[6] CG Oncol, Irvine, CA USA
来源：
MOLECULAR THERAPY | 2021年 / 29卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
659
引用
收藏
页码：320 / 320
页数：1
相关论文
共 50 条
  • [21] HEALTHCARE RESOURCE USE (HCRU) OF NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) PATIENTS POST BACILLUS CALMETTE-GUERIN (BCG)-UNRESPONSIVE STATUS IN MULTIPLE COUNTRIES
    Broughton, E.
    Chun, D.
    Gooden, K.
    Mycock, K.
    Rajkovic, I
    Taylor-Stokes, G.
    VALUE IN HEALTH, 2020, 23 : S484 - S485
  • [22] Bacillus Calmette-Guerin treatment of non-muscle invasive bladder cancer
    Sylvester, Richard J.
    INTERNATIONAL JOURNAL OF UROLOGY, 2011, 18 (02) : 113 - 120
  • [23] Bacillus Calmette-Guerin (BCG) Treatment Failures in Non-Muscle Invasive Bladder Cancer: What Truly Constitutes Unresponsive Disease
    Steinberg, Ryan L.
    Thomas, Lewis J.
    O'Donnell, Michael A.
    BLADDER CANCER, 2015, 1 (02) : 105 - 116
  • [24] Pembrolizumab for high-risk (HR) non-muscle invasive bladder cancer (NMIBC) unresponsive to bacillus Calmette-Guerin (BCG): Phase II KEYNOTE-057 trial
    de Wit, R.
    Kulkarni, G. S.
    Uchio, E.
    Singer, E. A.
    Krieger, L.
    Grivas, P.
    Bajorin, D.
    Seo, H. K.
    Mourey, L.
    Kamat, A.
    Nishiyama, H.
    Kapadia, E.
    Nam, K.
    Frenkl, T.
    Balar, A.
    ANNALS OF ONCOLOGY, 2018, 29 : 304 - 304
  • [25] Phase 1 study of multi-dose administration of intravesical CG0070 in patients with non-muscle invasive bladder cancer (NMIBC)
    McKiernan, James M.
    Lamm, Donald L.
    Meng, Maxwell V.
    Nemunaitis, John J.
    Arseneau, James C.
    Stephenson, Joe
    Burke, James M.
    Aimi, Junko
    Maslyar, Daniel J.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 616 - 616
  • [26] Bacillus Calmette-Guerin (BCG) Treatment Failures with Non-Muscle Invasive Bladder Cancer: A Data-Driven Definition for BCG Unresponsive Disease
    Steinberg, Ryan L.
    Thomas, Lewis J.
    Mott, Sarah L.
    O'Donnell, Michael A.
    BLADDER CANCER, 2016, 2 (02) : 215 - 224
  • [27] Immunotherapy in Bacillus Calmette-Guerin (BCG) unresponsive nonmuscle invasive bladder cancer
    Hugar, Lee A.
    Gilbert, Scott M.
    Sexton, Wade J.
    Kamat, Ashish M.
    Li, Roger
    CURRENT OPINION IN UROLOGY, 2021, 31 (02) : 160 - 169
  • [28] Intravesical Thalidomide boosts bacillus Calmette-Guerin (BCG) in non-muscle invasive bladder cancer treatment
    Passos, Gabriela R.
    Camargo, Juliana A.
    Ferrari, Karen L.
    Saad, Mario J. A.
    de Mattos, Amilcar C.
    Reis, Leonardo O.
    MEDICAL ONCOLOGY, 2018, 35 (01)
  • [29] SINGLE INSTILLATION OF MITOMYCIN C (MMC) PLUS BACILLUS CALMETTE-GUERIN (BCG) VERSUS BCG ALONE IN HIGH GRADE NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
    Weiss, Brian
    Wein, Alan
    Malkowicz, S. Bruce
    Guzzo, Thomas
    JOURNAL OF UROLOGY, 2015, 193 (04): : E294 - E294
  • [30] RE-EVALUATION OF INTRAVESICAL GEMCITABINE IN BACILLUS CALMETTE-GUERIN UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER
    Escano, Manuel R. De Jesus
    Vertosick, Emily
    Benfante, Nicole
    Lenis, Andrew T.
    Reisz, Peter A.
    Goh, Alvin
    Cha, Eugene
    Donahue, Timothy F.
    Bochner, Bernard H.
    Sjoberg, Dan
    Pietzak, Eugene J.
    JOURNAL OF UROLOGY, 2021, 206 : E299 - E299
12345